A synthetic peptide for use as a blocking control in assays to test for specificity of DIRC2 antibody, Alternative Names: DIRC2 control peptide, DIRC2 antibody Blocking Peptide, Anti-DIRC2 Blocking Peptide, Disrupted In Renal Carcinoma 2 Blocking Peptide, FLJ14784 Blocking Peptide, RCC4 Blocking Peptide, DIRC2, DIRC-2, DIRC 2, DIRC-2 Blocking Peptide, DIRC 2 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
DIRC2
(Disrupted in Renal Carcinoma 2 (DIRC2))
Synonyme
MGC80843 Peptide, zgc:92095 Peptide, rcc4 Peptide, MGC69320 Peptide, RCC4 Peptide, disrupted in renal carcinoma 2 Peptide, disrupted in renal carcinoma 2 L homeolog Peptide, disrupted in renal carcinoma 2 (human) Peptide, DIRC2 Peptide, dirc2.L Peptide, dirc2 Peptide, Dirc2 Peptide
Hintergrund
DIRC2 is a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of DIRC2 by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.